Return to Clinical Trials Search Results

Safety Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia (NODE-303)

Primary: 1. The primary objective is to evaluate the safety of self-administered etripamil nasal spray (NS) outside of the clinical setting. Secondary Objectives: 1. To evaluate the efficacy of self-administered etripamil NS outside of the clinical setting, and 2. To evaluate the impact of etripamil NS on PSVT disease burden, and 3. To evaluate the safety and efficacy of etripamil NS when used for multiple PSVT episodes

Phase

III

Recruitment Status

Current Studies